List of bibliographic references indexed by molecular
Number of relevant bibliographic references: 832.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000012 (2020) |
E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique] | [Coronavirus and COVID-19 : focus on a galopping pandemic]. |
000043 (2020) |
Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan] | The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. |
000073 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
000077 (2020) |
Isabel Ortiz De Solorzano [Espagne] ; Karteek K. Bejagam ; Yaxin An ; Samrendra K. Singh ; Sanket A. Deshmukh | Solvation dynamics of N-substituted acrylamide polymers and the importance for phase transition behavior. |
000082 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
000087 (2020) |
Firas A. Rabi [Jordanie] ; Mazhar S. Al Zoubi [Jordanie] ; Ghena A. Kasasbeh [Jordanie] ; Dunia M. Salameh [Jordanie] ; Amjad D. Al-Nasser [Jordanie] | SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. |
000091 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
000136 (2020) |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
000140 (2020) |
Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine] | Molecular immune pathogenesis and diagnosis of COVID-19 |
000141 (2020) |
Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Shihui Sun [République populaire de Chine] ; Wanbo Tai [États-Unis] ; Jing Chen [République populaire de Chine] ; Qibin Geng [États-Unis] ; Lei He [République populaire de Chine] ; Yuehong Chen [République populaire de Chine] ; Jianming Wu [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] ; Fang Li [États-Unis] | Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. |
000142 (2020) |
Yuan Yuan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Ruchao Peng [République populaire de Chine] ; Chunrui Li [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Qihui Wang [République populaire de Chine] ; George Fu Gao [République populaire de Chine] | Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species. |
000143 (2020) |
Hongchun Li [République populaire de Chine] ; Pemra Doruker [États-Unis] ; Guang Hu [République populaire de Chine] ; Ivet Bahar [États-Unis] | Modulation of Toroidal Proteins Dynamics in Favor of Functional Mechanisms upon Ligand Binding. |
000162 (2020) |
Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. |
000170 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
000179 (2020) |
Mohsen Rokni [Iran] ; Vida Ghasemi [Iran] ; Zahra Tavakoli [Iran] | Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS. |
000186 (2020) |
Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
000227 (2020) |
Nashwa Hafez Zaher [Égypte] ; Mohammed Ismail Mostafa [Égypte] ; Abdullah Yousef Altaher | Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors. |
000235 (2020) |
Yaseen M. Arabi [Arabie saoudite] ; Robert Fowler [Canada] ; Frederick G. Hayden [États-Unis] | Critical care management of adults with community-acquired severe respiratory viral infection |
000257 (2020) |
Jenna Chaung [Singapour] ; Douglas Chan [Singapour] ; Surinder Pada [Singapour] ; Paul A. Tambyah [Singapour] | Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated. |
000267 (2020) |
Avinash Premraj [Émirats arabes unis] ; Abi George Aleyas [Émirats arabes unis] ; Binita Nautiyal [Émirats arabes unis] ; Thaha Jamal Rasool [Émirats arabes unis] | Camelid type I interferons: Identification and functional characterization of interferon alpha from the dromedary camel (Camelus dromedarius). |
000307 (2020) |
Yung-Fang Tu [Taïwan] ; Chian-Shiu Chien [Taïwan] ; Aliaksandr A. Yarmishyn [Taïwan] ; Yi-Ying Lin [Taïwan] ; Yung-Hung Luo [Taïwan] ; Yi-Tsung Lin [Taïwan] ; Wei-Yi Lai [Taïwan] ; De-Ming Yang [Taïwan] ; Shih-Jie Chou [Taïwan] ; Yi-Ping Yang [Taïwan] ; Mong-Lien Wang [Taïwan] ; Shih-Hwa Chiou [Taïwan] | A Review of SARS-CoV-2 and the Ongoing Clinical Trials. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "molecular"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "molecular" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= molecular
}}
| This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021 | |